Taiwan starts clinical trials of remdesivir on COVID-19 patients

Clinical trials of the antiviral drug remdesivir for the treatment of the coronavirus disease COVID-19 have already started in Taiwan, Central Epidemic Command Center (CECC) expert Chang Shang-chun (張上淳) said Thursday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)